Louisiana Administrative Code › Title 51 - PUBLIC HEALTH-SANITARY CODE › Part II - The Control of Diseases › Chapter 9 - Prevention and Control of Yellow Fever › Section II-905 - Yellow Fever Regulations [formerly paragraph 2:031]

Current through Register Vol. 50, No. 6, June 20, 2024
A. The following is a list of regulations of
				the Louisiana Department of Health and Hospitals, developed by the Office of
				Public Health, in conjunction with the USPHS Centers for Disease Control,
				Quarantine Division for non-federal facilities given the responsibility for
				administering and validating International Certificates of Vaccination or
				Revaccination against Yellow Fever.
1.
				[formerly paragraph 2:031-1] Any facility designated as a Yellow Fever
				Vaccination Center and issued a uniform stamp to validate International
				Certification of Vaccination against yellow fever shall be either a state,
				parish or municipal public health or a private medical clinic under full time
				supervision of a physician licensed by the Louisiana Board of Medical
				Examiners. The supervising physician must be fully knowledgeable of the
				procedures necessary for issuing a valid document. Written instructions with
				illustrations are included in Health Information for International Travel
				issued annually as a supplement to the Morbidity and Mortality Weekly Report of
				the Centers for Disease Control. Possession of a current book is mandatory for
				all approved centers.
2. [formerly
				paragraph 2:031-2] The uniform stamp:
a. is
				the property of the Office of Public Health and must be returned upon request
				via registered mail within 30 days of notification of cancellation;
b. is to be used to validate only those
				certificates issued by the approved non-federal medical facility;
c. should be kept in a safe place when not in
				use and must not be loaned or reproduced.
3. [formerly paragraph 2:031-3] Loss or theft
				of a uniform stamp must be reported immediately to the Office of Public Health
				which in turn shall report to the Division of Quarantine, Center for Prevention
				Services, Centers for Disease Control, Atlanta, Georgia 30333.
4. [formerly paragraph 2:031-4] Approval of
				and continued possession of the uniform stamp will be based on justified need
				and maintenance of policies compatible with the Office of Public Health
				guidelines. Reevaluations will be conducted semi-annually.
5. [formerly paragraph 2:031-5] Improperly
				prepared certificates bearing the uniform stamp as reported by the CDC Division
				of Quarantine at ports of entry will be further investigated by personnel of
				the Office of Public Health.
6.
				[formerly paragraph 2:031-6] The Office of Public Health shall maintain a
				listing of uniform stamps with corresponding identification codes. A duplicate
				listing shall be filed with the CDC Division of Quarantine.
7. "The Center must maintain adequate
				refrigeration to assure that the yellow fever vaccine will be kept in a
				refrigerated state with temperatures as recommended by the vaccine manufacturer
				and included in the storage recommendations of the vaccine package insert. Once
				the vaccine has been removed from refrigeration and reconstituted, it must be
				administered within 60 minutes. Any remaining unrefrigerated and unused vaccine
				must be destroyed."
8. [formerly
				paragraph 2:031-8] When a supervising physician named on the application is no
				longer associated with an approved center, the Office of Public Health shall be
				notified. Application procedures as stated below must be completed by the new
				replacement supervising physician.
9. [formerly paragraph 2:031-9] Approved
				centers are required to keep records of persons whose International
				Certificates of Vaccination or Revaccination against Yellow Fever are validated
				and to submit periodic (six months) reports covering operations to the Office
				of Public Health. All designated centers are required to report adverse
				reactions to yellow fever vaccine of sufficient severity to require medical
				attention.
a. Adverse reactions or other
				complications occurring within 30 days of the receipt of the vaccine shall be
				reported:
i. neurologic reactions-meningitis,
				encephalitis, polyneuropathy, guillain-barre syndrome, paralysis;
ii. allergic reactions-urticaria, asthma,
				angioneurotic edema, erythema multiforme, anaphylaxis, other;
iii. other post vaccination
				complications-acute febrile illness with headache, malaise, Barthralgia, or
				jaundice.
10.
				[formerly paragraph 2:031-10] International Certificates of Vaccination must
				conform to International Health Regulations, Chapter III, Article 79, World
				Health Organization.
11. [formerly
				paragraph 2:031-11] The approved center shall develop, implement and maintain a
				procedure for handling emergencies due to severe vaccine reactions such as
				anaphylaxis, including the maintenance of necessary supplies and medicine to
				provide life support until patient can be transferred safely to an acute care
				facility.
12. [formerly paragraph
				2:031-12] The state health officer may order additional procedures to ensure
				compliance with the provision of these regulations and reserves the authority
				to enforce any regulation not so specified in this rule that is considered to
				be medically significant in the operation of such clinics.
13. [formerly paragraph 2:031-13] The
				supervising physician is responsible for his or her practices regarding
				administration of immunizations.
14. [formerly paragraph 2:031-14] Proper
				infectious waste handling and disposal shall be done in accordance with the
				Louisiana Sanitary Code, Part XXVII.